Chickasaw Capital Management LLC trimmed its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 17.4% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 950 shares of the healthcare conglomerate’s stock after selling 200 shares during the period. Chickasaw Capital Management LLC’s holdings in UnitedHealth Group were worth $237,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. IMS Capital Management bought a new position in shares of UnitedHealth Group in the third quarter worth about $85,000. Worth Venture Partners LLC bought a new position in shares of UnitedHealth Group in the third quarter worth about $104,000. FNY Investment Advisers LLC bought a new position in shares of UnitedHealth Group in the third quarter worth about $106,000. Polaris Greystone Financial Group LLC bought a new position in shares of UnitedHealth Group in the third quarter worth about $120,000. Finally, Fort L.P. bought a new position in shares of UnitedHealth Group in the second quarter worth about $119,000. Hedge funds and other institutional investors own 85.28% of the company’s stock.
A number of research analysts have recently commented on UNH shares. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 18th. Raymond James increased their target price on shares of UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a report on Monday, September 24th. Bank of America increased their target price on shares of UnitedHealth Group from $315.00 to $320.00 and gave the stock a “buy” rating in a report on Wednesday, October 17th. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday, October 2nd. Finally, Jefferies Financial Group increased their target price on shares of UnitedHealth Group from $270.00 to $311.00 and gave the stock a “buy” rating in a report on Wednesday, October 3rd. One analyst has rated the stock with a hold rating and twenty-three have given a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and a consensus target price of $292.33.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, beating analysts’ consensus estimates of $3.30 by $0.11. The business had revenue of $56.56 billion during the quarter, compared to the consensus estimate of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The company’s revenue for the quarter was up 12.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.66 EPS. On average, sell-side analysts expect that UnitedHealth Group Inc will post 12.81 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd were given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.45%. The ex-dividend date of this dividend was Friday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 35.75%.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 163 shares of the stock in a transaction that occurred on Friday, November 9th. The shares were sold at an average price of $274.83, for a total transaction of $44,797.29. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 6,090 shares of the stock in a transaction that occurred on Wednesday, November 28th. The shares were sold at an average price of $281.72, for a total transaction of $1,715,674.80. Following the sale, the director now directly owns 1,711,584 shares of the company’s stock, valued at approximately $482,187,444.48. The disclosure for this sale can be found here. Corporate insiders own 0.87% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: What impact do institutional investors have on markets?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.